leftspacer middlespacer rightspacer
Media Menu
Featured Material


MAPS BULLETIN
MAPS Bulletin Winter 2013: 2013 Annual Report
 
Media > Recent and Archival
December 13, 2013

Psychedelic Medicine: Worth the Trip?

By: Professor David J. Nutt, MD, and Bret S. Stetka, MD

Medscape

Medscape hosts a slideshow presentation about the resurgence of research into the potential medical benefits of psychedelic substances. Written by Professor David J. Nutt, MD, and Bret S. Stetka, MD, this educational resource touches upon the history of psychedelics, details about the medical potential of MDMA, LSD, psilocybin, and ibogaine.


Originally appearing here.

Psychedelic compounds have been used medicinally for millennia. Ancient Chinese, African, and South American healers prescribed them for various primarily psychiatric ailments, as did early Ayurvedic practitioners in India and possibly far older prehistoric cultures. One recent study cites the possible influence of psychedelics on 40,000-year-old Paleolithic cave art. Despite extensive early 20th century interest in hallucinogens as therapy, modern medicine mostly abandoned research into their therapeutic potential, as governments worldwide criminalized agents such as LSD, psilocybin, and mescaline in reaction to their counterculture use in the 1960s. But scattered clinical curiosity over the years and a recent renewed interest in psychedelic treatments have hallucinogens again emerging as possible psychiatric therapies, or at least as pharmacologic leads on related and potentially helpful compounds.

View the full slideshow here.


Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.